Kurt Brown

2.3k total citations
36 papers, 1.8k citations indexed

About

Kurt Brown is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Kurt Brown has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 10 papers in Epidemiology and 8 papers in Genetics. Recurrent topics in Kurt Brown's work include Microscopic Colitis (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Inflammatory Bowel Disease (7 papers). Kurt Brown is often cited by papers focused on Microscopic Colitis (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Inflammatory Bowel Disease (7 papers). Kurt Brown collaborates with scholars based in United States, United Kingdom and Sweden. Kurt Brown's co-authors include Eduardo D. Ruchelli, William J. Wenner, Chris A. Liacouras, Robert N. Baldassano, Jonathan E. Markowitz, Petar Mamula, J. Næsdal, Paul A. Offit, David A. Piccoli and Theresa M. Voytek and has published in prestigious journals such as Gastroenterology, Gut and The Journal of Infectious Diseases.

In The Last Decade

Kurt Brown

33 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Brown United States 21 886 506 403 347 345 36 1.8k
C Folwaczny Germany 24 384 0.4× 134 0.3× 565 1.4× 388 1.1× 486 1.4× 73 2.0k
S. Koskimies Finland 24 303 0.3× 391 0.8× 389 1.0× 328 0.9× 482 1.4× 83 1.8k
J Vilaseca Spain 22 623 0.7× 107 0.2× 686 1.7× 514 1.5× 168 0.5× 76 1.9k
Kouhei Fukushima Japan 25 689 0.8× 77 0.2× 756 1.9× 466 1.3× 435 1.3× 111 2.3k
Danilo Villalta Italy 28 895 1.0× 284 0.6× 283 0.7× 1.1k 3.1× 278 0.8× 81 2.7k
Roy E. Pounder United Kingdom 23 647 0.7× 52 0.1× 505 1.3× 548 1.6× 285 0.8× 41 1.7k
P. L. Giorgi Italy 21 543 0.6× 116 0.2× 418 1.0× 861 2.5× 162 0.5× 76 2.1k
L.A. Turnberg United Kingdom 17 510 0.6× 196 0.4× 108 0.3× 134 0.4× 103 0.3× 33 1.3k
Maria Pastore Italy 21 696 0.8× 53 0.1× 551 1.4× 194 0.6× 204 0.6× 92 1.8k
Christian Felley Switzerland 25 1.1k 1.2× 69 0.1× 885 2.2× 689 2.0× 224 0.6× 71 2.1k

Countries citing papers authored by Kurt Brown

Since Specialization
Citations

This map shows the geographic impact of Kurt Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Brown more than expected).

Fields of papers citing papers by Kurt Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Brown. The network helps show where Kurt Brown may publish in the future.

Co-authorship network of co-authors of Kurt Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Brown. A scholar is included among the top collaborators of Kurt Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Brown. Kurt Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Haens, Geert, William J. Sandborn, Jean‐Frédéric Colombel, et al.. (2014). A phase II study of laquinimod in Crohn's disease. Gut. 64(8). 1227–1235. 64 indexed citations
2.
Sandström, Marie, Geoffrey P. Davidson, Vasundhara Tolia, et al.. (2012). Phase I, Multicenter, Randomized, Open-Label Study Evaluating the Pharmacokinetics and Safety Profile of Repeated Once-Daily Doses of Intravenous Esomeprazole in Children 0 to 17 Years of Age. Clinical Therapeutics. 34(8). 1828–1838. 12 indexed citations
3.
Goldstein, Jay L., John F. Johanson, Christopher J. Hawkey, Lisa Suchower, & Kurt Brown. (2007). Clinical trial: healing of NSAID‐associated gastric ulcers in patients continuing NSAID therapy – a randomized study comparing ranitidine with esomeprazole. Alimentary Pharmacology & Therapeutics. 26(8). 1101–1111. 40 indexed citations
4.
Markowitz, Jonathan E., et al.. (2007). Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences. 52(2). 365–372. 19 indexed citations
5.
Næsdal, J. & Kurt Brown. (2006). NSAID-Associated Adverse Effects and Acid Control Aids to Prevent Them. Drug Safety. 29(2). 119–132. 92 indexed citations
6.
Johnson, David A., William C. Orr, Joseph A. Crawley, et al.. (2005). Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial. The American Journal of Gastroenterology. 100(9). 1914–1922. 160 indexed citations
7.
Ruchelli, Eduardo D., et al.. (2004). Intestinal Interleukin-13 in Pediatric Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases. 10(5). 593–598. 31 indexed citations
8.
Matthews, Randolph P. & Kurt Brown. (2003). A 1-Month-Old With Prolonged Jaundice. PubMed. 3(2). 63–74.
9.
Stephens, Michael C., Melissa A. Shepanski, Petar Mamula, et al.. (2003). Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. The American Journal of Gastroenterology. 98(1). 104–111. 93 indexed citations
10.
Ruchelli, Eduardo D., et al.. (2003). Intestinal cytokines in children with pervasive developmental disorders. The American Journal of Gastroenterology. 98(8). 1777–1782. 30 indexed citations
11.
Mamula, Petar, Jonathan E. Markowitz, Kurt Brown, et al.. (2002). Infliximab as a Novel Therapy for Pediatric Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 34(3). 307–311. 52 indexed citations
12.
Mamula, Petar, Jonathan E. Markowitz, Kurt Brown, et al.. (2002). Infliximab as a Novel Therapy for Pediatric Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 34(3). 307–311. 12 indexed citations
13.
Brown, Kurt, Susan J. Back, Eduardo D. Ruchelli, et al.. (2002). Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. The American Journal of Gastroenterology. 97(10). 2603–2608. 45 indexed citations
14.
Brown, Kurt & Dilip Moonka. (2001). Liver transplantation. Current Opinion in Gastroenterology. 17(3). 299–303. 11 indexed citations
15.
Markowitz, James, Kurt Brown, Petar Mamula, et al.. (2001). Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease. The American Journal of Gastroenterology. 96(9). 2688–2690. 19 indexed citations
16.
Brown, Kurt & Paul A. Offit. (1998). Rotavirus-specific proteins are detected in murine macrophages in both intestinal and extraintestinal lymphoid tissues. Microbial Pathogenesis. 24(6). 327–331. 47 indexed citations
17.
Liacouras, Chris A., William J. Wenner, Kurt Brown, & Eduardo D. Ruchelli. (1998). Primary Eosinophilic Esophagitis in Children: Successful Treatment with Oral Corticosteroids. Journal of Pediatric Gastroenterology and Nutrition. 26(4). 380–385. 387 indexed citations
18.
Brown, Kurt, et al.. (1997). Aqueous-based microcapsules are detected primarily in gut-associated dendritic cells after oral inoculation of mice. Vaccine. 15(17-18). 1959–1962. 24 indexed citations
19.
Brown, Kurt. (1996). Facing the lion. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026